| Company | Drug Candidates | Research Platforms | Positions | Contact |

Syntrix Biosystems develops novel therapeutics and research platforms

 through innovative research and discovery

Drug Candidates Compound Pipeline Clinical Candidates Clinical Trials

Research Platforms Genomics Tissue Analysis

• Aminopterin in Phase 2 clinical trials in pediatric leukemia

• Syntrix awarded grant from NIH for clinical trial of aminopterin in psoriasis

• Syntrix issued US Patent Number 6,569,598

• Syntrix acquires worldwide exclusive rights to GST inhibitors from the University of Washington

• Syntrix awarded two grants from NIH to develop artificial antibodies for proteomics

• Syntrix acquires worldwide exclusive rights to NMDA inhibitors from the University of Medicine and Dentistry of New Jersey

• Syntrix awarded a Fast-Track grant from NCI to develop a system for the high-resolution analysis of cancer tissues

Syntrix Biosystems, Inc.

215 Clay Street NW, Suite B-5, Auburn, WA  98001

TEL: 253-833-8009 • FAX: 253-833-8127

© Copyright 2007 Syntrix Biosystems. All Rights Reserved.